Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Hospira, Inc. | Location not on file | Tests it | Not inspected on record |
Recalls
- Aug 4, 2025 · Class II · Pfizer Inc
Lack of Assurance of Sterility.
Lots: Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Epinephrine: every company that makes it
- Form
- injection, solution
- Strength
- 0.1 mg per 1 mL
- Approval
- NDA NDA209359
- On the market since
- Mar 10, 2021
- Package NDCs
0409-4933-010409-4933-050409-4933-100409-4933-11- Official label
- DailyMed (National Library of Medicine), updated Jun 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?